Global Stem Cell Therapy Market Future Outlook Stem cells are specialized cells that can differentiate into other cells without losing their identity. They have been found to be present in animals as well as humans and most of the
work has been done on mice. Investigators have found that stem cells are part of repair system and helps in maintaining the normal bodily functions. They divide to give rise to two cells out of which one remains the same while other differentiates into the required cell
type. They can replenish throughout the life-time and they could repair damaged organs in order to prevent further damage. They are also influenced by external cues due to which they
could be converted into different cell type. It is expected that investigators would be able to
make new discoveries that would allow them to assign new properties to stem cells. More research is required in this segment to fully understand the properties of stem cells.
Investigators are trying to decipher stem cells biochemical and biophysical properties so that they could develop them as a therapeutic commodity. Their ability to convert into different cell types could be used for developing regenerative medicines. Organ regeneration at
laboratory levels have been achieved but it will take some time for developing fully
functional transplantable organ. Investigators have found they could be used for various
oncological applications. Modified stem cells could be used for curing cancer and some success has been achieved in past years. Their utility in cardiovascular diseases has been noted as they have ability to regenerate damaged cardiac muscles. In neural disorders like Alzheimer’s disease and Parkinson’s disease their role is being studied as presently available therapeutics have modest efficacy with short-lived effects.
Innovations in pharmaceutical industry seem to be the main driving force for the development
of stem cell therapies. Investigators have been able to identify different stem cell sources which offers them large base for developing new therapies. Their customizability and
appropriate usage is expected to help them to discover new pharmacological properties that may have high commercialization potential. As a result, large numbers of stem cell therapies are entering in clinical trials across the globe. They are at different stages of development
and likely to be introduced in global market in coming years. This will help the stem cell
therapy developers to generate significant revenues in coming years. However, this scenario may take few years to materialize but some stem cell therapies have already entered in market which are in clinical practice for past years.
For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 1
Global Stem Cell Therapy Market Future Outlook As per recent research report "Global Stem Cell Therapy Market Future Outlook " published by
KuicK Research, advancement in stem cell research seems to be increasing continuously
across the globe which is apparent from the number of increasing clinical trials. Stem cell therapies for numerous indications are at different stages of clinical trials and they would be
introduced in market in coming years. Increased findings and quest for better therapeutics could be considered as main reason behind growth of this segment. Improved technology and development of innovative modalities are further expected to propel the development of
stem cell therapies. Only few stem cell therapies have received approval and most of them are small part of forth coming medical revolution. Stem cell therapy developers would be able to generate significant revenues in coming years. In this way, future prospects of stem
cell therapies look optimistic and it is expected that more stem cell therapies would be commercialized in coming years.
"Global Stem Cell Therapy Market Future Outlook" Report Highlight: • • • • • • • •
Global Stem Cell Market Analysis
Trends in Stem Cell Research
Global Stem Cell Market Dynamics: Favorable Factors & Commercialization Challenges
Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase
Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies
Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies
Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication
Marketed Stem Cell Therapies Clinical: 2 Therapies (Adipocell® & VesCell™)
For Report Sample Contact: neeraj@kuickresearch.com
For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 2
Global Stem Cell Therapy Market Future Outlook Table of Contents 1. Introduction to Stem Cells 2. Classification of Stem Cells 2.1 Basis of Ability to Differentiate 2.2 Basis of Origin 2.3 Basis of their Source 3. Different Type of Stem Cell Transplants 3.1 Autologous Stem Cell Transplants 3.2 Allogeneic Stem Cell Transplants 3.3 Syngeneic Stem Cell Transplants 4. Mechanism of Stem Cell Therapy 5. Trends in Stem Cell Research 5.1 Stem Cell Therapy for Cardiovascular Diseases 5.2 Stem Cell Therapy for Cancer Treatment 5.3 Stem Cell Therapy for Central Nervous System Disorders 5.4 Stem Cell Therapy for Ophthalmic Disorders 5.5 Stem Cell Therapy for Metabolic Disorders 5.6 Stem Cell Therapy for Gastrointestinal Diseases 6. Global Stem Cell Market Analysis 6.1 Current Market Scenario 6.2 Global Stem Cell Therapies Pipeline Overview 7. Global Stem Cell Market Dynamics 7.1 Favorable Factors 7.2 Commercialization Challenges For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 3
Global Stem Cell Therapy Market Future Outlook 8. Stem Cell Market Future Prospects 9. Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase 9.1 Research 9.2 Preclinical 9.3 Clinical 9.4 Phase-I 9.5 Phase-I/II 9.6 Phase-II 9.7 Phase-III 9.8 Registered 10. Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication 10.1 Adipose Stem Cell Therapy (AdipocellŽ) 10.2 Angiogenic Cell Precursor Therapy (VesCell™) 11. Discontinued & Suspended Stem Cell Therapies in Clinical Pipeline 11.1 No Development Reported 11.2 Discontinued 11.3 Suspended 12. Competitive Landscape 12.1 Aldagen 12.2 AlloCure 12.3 Anterogen 12.4 Arteriocyte Medical Systems 12.5 Athersys Inc. 12.6 Baxter Healthcare Corporation For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 4
Global Stem Cell Therapy Market Future Outlook 12.7 Bioheart 12.8 Cambridge Enterprise Ltd 12.9 Celyad 12.10 Celgene Corporation 12.11 Cellerant Therapeutics 12.12 Cellonis Biotechnologies 12.13 CellPraxis 12.14 Chiesi 12.15 Caladrius 12.16 Cryopraxis 12.17 Cytori Therapeutics 12.18 Gamida Cell 12.19 Genexine 12.20 Geron 12.21 Intrexon Corporation 12.22 K-STEMCELL 12.23 Lifecells LLC 12.24 Medipost 12.25 Medistem Panama 12.26 Mesoblast 12.27 Novartis 12.28 Nuo Therapeutics 12.29 Ocata Therapeutics 12.30 OmniCyte Ltd For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 5
Global Stem Cell Therapy Market Future Outlook 12.31 OncoMed 12.32 Osiris Therapeutics 12.33 Pharmicell 12.34 Pluristem Therapeutics 12.35 Promethera Biosciences 12.36 ReNeuron 12.37 Stem Cell Sciences (SCS) 12.38 Stem Cells 12.39 Stemedica Cell Technologies 12.40 TCA Cellular Therapy 12.41 TheraVitae 12.42 TiGenix 12.43 Vericel Corporation
List of Figures Figure 1-1: Properties of Stem Cells Figure 1-2: Utility of Stem Cells Figure 1-3: Benefits of Stem Cells Figure 1-4: Limitations of Stem Cells Figure 2-1: Type of Stem Cells on the Basis of Ability to Differentiate Figure 2-2: Type of Stem Cells on the Basis of Origin Figure 2-3: Types of Stem Cells on the Basis of their Source Figure 2-4: Different Sources of Autologous Stem Cell For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 6
Global Stem Cell Therapy Market Future Outlook Figure 3-1: Different Stem Cell Transplants Figure 4-1: Source of Hematopoietic Stem Cells Figure 4-2: Mechanism of Stem Cells Blood Related Diseases Figure 4-3: Mechanism of Skin treatment by Stem Cells Figure 4-4: Mechanism of Stem Cell Diabetes Treatment Figure 5-1: Relevant Type of Stem Cells for CVS Figure 5-2: Proposed Mechanism of Stem Cell Activity Figure 6-1: Difference between Autologous & Autogenic HSCTs Figure 6-2: Global Stem Cell Market Opportunity (US$ Billion), 2015-2020 Figure 6-3: Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015 Figure 6-4: Global Stem Cell Therapies Clinical Pipeline by Phase (Number), 2015 Figure 6-5: No Development Reported Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015 Figure 6-6: No Development Reported Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015 Figure 6-7: Discontinued Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015 Figure 6-8: Discontinued Global Stem Cell Therapies Clinical Pipeline by Phase (Number), 2015 Figure 7-1: Global Stem Cell Market Favorable Parameters Figure 7-2: Global Stem Cell Market Commercialization Challenges Figure 12-1: Anterogen - Clinical Pipeline Figure 12-2: Arteriocyte Medical Systems Clinical Pipeline Figure 12-3: Bioheart-Clinical Pipeline Figure 12-4: Celgene-Clinical Pipeline Figure 12-5: Cellerant-Therapeutics Clinical Pipeline Figure 12-6: Caladrius-Clinical Pipeline For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 7
Global Stem Cell Therapy Market Future Outlook Figure 12-7: Gamida Cell- Clinical Pipeline Figure 12-8: Genexie-Clinical Pipeline Figure 12-9: Mesoblast Clinical Pipeline Figure 12-10:OncoMed-Clinical Pipeline Figure 12-11: Osiris Therapeutics- Clinical Pipeline Figure 12-12: Pharmicell-Clinical Pipeline Figure 12-13: Promethera- Clinical Pipeline Figure 12-14: ReNeuron-Clinical Pipeline Figure 12-15: Stem Cell-Clinical Pipeline Figure 12-16: Vericel –Clinical Pipeline
Table 2-1: Difference between Embryonic, Adult & Induced Stem Cells Table 3-1: Comparison between Different Types of Stem Cell Transplants Table 3-2: Few Autologous Stem Cell Therapies under Development Table 4-1: Different Stem Cells used for Skin Treatment
For Report Sample Contact: neeraj@kuickresearch.com
For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 8
Global Stem Cell Therapy Market Future Outlook
For Sample Contact: neeraj@kuickresearch.com , +91-11-47067990
Page 9